Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Ugeskrift for Laeger|March 18, 2014
[Simplification of procedures for clinical drug trials in the EU is coming up]Karin Friis Bach, Annette Jørgensen
Basic & Clinical Pharmacology & Toxicology|January 30, 2004
Good clinical practice is now obligatory in academic clinical drug research in the European UnionAnnette Jørgensen, Karin Friis Bach, Karen Friis
The Journal of Reproductive Medicine|June 20, 2006
Fetal exposure to pimozide: a case reportNina H Bjarnason, Line Rode, Kim Dalhoff
Plos One|May 10, 2017
Barriers towards the publication of academic drug trials. Follow-up of trials approved by the Danish Medicines AgencyLouise Berendt, Lene Grejs Petersen, Karin Friis Bach, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
A Paradigm Shift Towards Patient Involvement in Medicines Development and Regulatory Science: Workshop Proceedings and CommentaryGitte Borup, Karin Friis Bach, Merete Schmiegelow, et al.
Trials|February 21, 2016
From protocol to published report: a study of consistency in the reporting of academic drug trialsLouise Berendt, Torbjörn Callréus, Lene Grejs Petersen, et al.
Basic & Clinical Pharmacology & Toxicology|January 21, 2009
The effect of aromatase inhibitors on bone metabolismLars Folkestad, Nina H Bjarnason, Jon Kroll Bjerregaard, et al.
Acta Oncologica (Stockholm, Sweden)|May 10, 2008
Adverse bone effects during pharmacological breast cancer therapyNina H Bjarnason, Mette Hitz, Niklas R Jorgensen, et al.
Ugeskrift for Laeger|June 1, 2007
[Effect of aromatase inhibitors on bone metabolism]Lars Folkestad, Jon Kroll Bjerregaard, Nina H Bjarnason, et al.
Maturitas|January 7, 2004
Associated response in bone and lipids during hormone replacement therapyAnne Bloch Thomsen, Sandra Silvestri, Jens Haarbo, et al.
Pageof 2